The QMN Weekly Bulletin

Dec. 30, 2011 | Vol. 3 No. 52

Compliance, Quality Issues Cast Shadow on Pharma Deals

Global drugmakers may have turned risk-averse toward buying or forming partnerships with Indian makers of generic medicines after being hit by revenue losses stemming from quality and compliance issues over previous acquisitions and tie-ups.
LiveMint

Register Now
Print This Page
Email This Article
RSS
Archives

Gilead Form 483 Provides Insight Into FDA’s Rejection of HIV Drugs UDI Final Rule Takes Industry Advice, But Will Still Pose Challenges: Experts Baxter Warned Over Contamination, GMP Deviations at Two Plants China, India Fine-Tuning GMPs as API Makers Rush to Meet New EU Rules

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.